Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3142)
All Articles published online
|
Feb 15, 2001 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Feng DY, Zheng H, Tan Y, Cheng RX. Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance. World J Gastroenterol 2001; 7(1): 33-36 [PMID: 11819729 DOI: 10.3748/wjg.v7.i1.33] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i1/33.htm |
| Number | Citing Articles |
| 1 |
Melanie B. Thomas, James L. Abbruzzese. Opportunities for Targeted Therapies in Hepatocellular Carcinoma. Journal of Clinical Oncology 2005; 23(31): 8093 doi: 10.1200/JCO.2004.00.1537
|
| 2 |
Chun-Hui Wang, Cheng-Wei Tang, Chun-Lun Liu, Li-Ping Tang. Inhibitory effect of octreotide on gastric cancer growth <italic>via</italic> MAPK pathway. World Journal of Gastroenterology 2003; 9(9): 1904-1908 doi: 10.3748/wjg.v9.i9.1904
|
| 3 |
Jin-fang Zhang, Ming-liang He, Wei-ming Fu, Hua Wang, Lian-zhou Chen, Xiao Zhu, Ying Chen, Dan Xie, Paul Lai, Gong Chen, Gang Lu, Marie C.M. Lin, Hsiang-fu Kung. Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Hepatology 2011; 54(6): 2137 doi: 10.1002/hep.24595
|
| 4 |
Jennifer L. Giglia, Scott J. Antonia, Lawrence B. Berk, Salvador Bruno, Sophie Dessureault, Steven E. Finkelstein. Systemic Therapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future. Cancer Control 2010; 17(2): 120 doi: 10.1177/107327481001700207
|
| 5 |
Kodappully Sivaraman Siveen, Sakshi Sikka, Rohit Surana, Xiaoyun Dai, Jingwen Zhang, Alan Prem Kumar, Benny K.H. Tan, Gautam Sethi, Anupam Bishayee. Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1845(2): 136 doi: 10.1016/j.bbcan.2013.12.005
|
| 6 |
Sheau-Fang Yang, Yao-Tsung Yeh, Shen-Nien Wang, Sz-Chi Hung, Wan-Tzu Chen, Chu-Ho Huang, Chee-Yin Chai. SOCS-3 is associated with vascular invasion and overall survival in hepatocellular carcinoma. Pathology 2008; 40(6): 558 doi: 10.1080/00313020802320432
|
| 7 |
Gang Liu, Guojun Hou, Liang Li, Yixue Li, Weiping Zhou, Lei Liu. Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo. Oncotarget 2016; 7(22): 32607 doi: 10.18632/oncotarget.8927
|
| 8 |
Zheng-Xu Wang, Gui-Fang Hu, Hong-Yang Wang, Meng-Chao Wu. Expression of liver cancer associated gene HCCA3. World Journal of Gastroenterology 2001; 7(6): 821-825 doi: 10.3748/wjg.v7.i6.821
|
| 9 |
Hyuk Moon, Simon Weonsang Ro. Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma. Journal of Liver Cancer 2021; 21(1): 1 doi: 10.17998/jlc.21.1.1
|
| 10 |
Carol Lee, Siu Tim Cheung. STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma. Cancers 2019; 11(11): 1646 doi: 10.3390/cancers11111646
|
| 11 |
Nada M.K. Mabrouk, Dalal M. Elkaffash, Mona Abdel-Hadi, Salah-ElDin Abdelmoneim, Sameh Saad ElDeen, Gihan Gewaifel, Khaled A. Elella, Maher Osman, Nahed Baddour. Identification of the possible therapeutic targets in the insulin-like growth factor 1 receptor pathway in a cohort of Egyptian hepatocellular carcinoma complicating chronic hepatitis C type 4. Drug Target Insights 2020; 14(1): 1 doi: 10.33393/dti.2020.1548
|
| 12 |
Yan Chen, Qiao Wu, Si-Yang Song, Wen-Jin Su. Activation of JNK by TPA promotes apoptosis via PKC pathway in gastric cancer cells. World Journal of Gastroenterology 2002; 8(6): 1014-1018 doi: 10.3748/wjg.v8.i6.1014
|
| 13 |
Su-Hong Chen, Dan-Dan Xu, Peng-Jun Zhou, Yao Wang, Qiu-Ying Liu, Zhe Ren, Zhong Liu, Xia Wang, Hui-Qing Huang, Xue Xue, Ying Wang, Yi-Fei Wang. Combination treatment with sorafenib and wh‑4 additively suppresses the proliferation of liver cancer cells. Experimental and Therapeutic Medicine 2022; 23(3) doi: 10.3892/etm.2022.11156
|
| 14 |
Melanie Thomas. Molecular targeted therapy for hepatocellular carcinoma. Journal of Gastroenterology 2009; 44(S19): 136 doi: 10.1007/s00535-008-2252-z
|
| 15 |
Melanie B. Thomas. Systemic Therapy for Hepatocellular Carcinoma. The Cancer Journal 2008; 14(2): 123 doi: 10.1097/PPO.0b013e31816a6058
|
| 16 |
Ming-Yao Wu, Chu-Xiang Zhuang, Huan-Xing Yang, Ying-Rui Liang. Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and <i>in situ</i> hybridization study. World Journal of Gastroenterology 2004; 10(4): 476-480 doi: 10.3748/wjg.v10.i4.476
|
| 17 |
George Papatsimbas, Christina Chatedaki, Dimitris Zacharoulis. Targeted Therapies for Hepatocellular Carcinoma. 2011; : 34 doi: 10.2217/ebo.11.226
|
| 18 |
Mamoun Younes, Lin Zhang, Baharan Fekry, Kristin Eckel-Mahan. Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD). Oncotarget 2022; 13(1): 1308 doi: 10.18632/oncotarget.28324
|
| 19 |
Aruljothi Subramaniam, Muthu K. Shanmugam, Ekambaram Perumal, Feng Li, Alamelu Nachiyappan, Xiaoyun Dai, Shivananju Nanjunda Swamy, Kwang Seok Ahn, Alan Prem Kumar, Benny K.H. Tan, Kam Man Hui, Gautam Sethi. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2013; 1835(1): 46 doi: 10.1016/j.bbcan.2012.10.002
|
| 20 |
Rui Zhang, Jie Sun, Yan Zhang, Shupei Cheng, Xiaowei Zhang. Signal transduction disturbance related to hepatocarcinogenesis in mouse by prolonged exposure to Nanjing drinking water. Environmental Science and Pollution Research 2013; 20(9): 6468 doi: 10.1007/s11356-013-1695-9
|
| 21 |
Qin Pan, Ding-Guo Li, Han-Ming Lu, Liang-Yong Lu, Yu-Qin Wang, Qin-Fang Xu. Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells. World Journal of Gastroenterology 2004; 10(7): 1015-1018 doi: 10.3748/wjg.v10.i7.1015
|
| 22 |
Aruljothi Subramaniam, Muthu K. Shanmugam, Ekambaram Perumal, Feng Li, Alamelu Nachiyappan, Alan P. Kumar, Benny K. H. Tan, Gautam Sethi. Perspectives in Cancer Prevention-Translational Cancer Research. 2014; : 73 doi: 10.1007/978-81-322-1533-2_6
|
| 23 |
Qiong-Qiong He, Rui-Xue Cheng, Yi Sun, De-Yun Feng, Zhu-Chu Chen, Hui Zheng. Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 C-terminal deleted protein. World Journal of Gastroenterology 2003; 9(3): 474-478 doi: 10.3748/wjg.v9.i3.474
|
| 24 |
Xiao-Zhong Wang, Xiang-Rong Jiang, Xiao-Chun Chen, Zhi-Xing Chen, Dan Li, Jian-Yin Lin, Qi-Min Tao. Seek protein which can interact with hepatitis B virus X protein from human liver cDNA library by yeast two-hybrid system. World Journal of Gastroenterology 2002; 8(1): 95-98 doi: 10.3748/wjg.v8.i1.95
|
| 25 |
M. Ionta, M.C. Rosa, R.B. Almeida, V.M. Freitas, P. Rezende-Teixeira, G.M. Machado-Santelli. Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation. Brazilian Journal of Medical and Biological Research 2012; 45(8): 721 doi: 10.1590/S0100-879X2012007500087
|
| 26 |
Wen-Chang Li, Sheng-Long Ye, Rui-Xia Sun, Yin-Kun Liu, Zhao-You Tang, Youngsoo Kim, James G. Karras, Hong Zhang. Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3. Clinical Cancer Research 2006; 12(23): 7140 doi: 10.1158/1078-0432.CCR-06-0484
|
| 27 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_167-1
|
| 28 |
Chuan-Hai Zhang, Ge-Liang Xu, Wei-Dong Jia, Jian-Sheng Li, Jin-Liang Ma, Wei-Hua Ren, Yong-Sheng Ge, Ji-Hai Yu, Wen-Bin Liu, Wei Wang. Activation of STAT3 Signal Pathway Correlates with Twist and E-Cadherin Expression in Hepatocellular Carcinoma and Their Clinical Significance. Journal of Surgical Research 2012; 174(1): 120 doi: 10.1016/j.jss.2010.10.030
|
| 29 |
Shuai Li, Hanjiang Fu, Yulan Wang, Yi Tie, Ruiyun Xing, Jie Zhu, Zhixian Sun, Lixin Wei, Xiaofei Zheng. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology 2009; 49(4): 1194 doi: 10.1002/hep.22757
|
| 30 |
Marisa Dolled-Filhart, David L. Rimm. Signal Transducers and Activators of Transcription (STATs). 2003; : 697 doi: 10.1007/978-94-017-3000-6_44
|
| 31 |
Neil J. Manimala, Chelsea D. Frost, Meghan L. Lane, Mariana Higuera, Rana Beg, David L. Vesely. Cardiac hormones target nuclear oncogenes c‐Fos and c‐Jun in carcinoma cells. European Journal of Clinical Investigation 2013; 43(11): 1156 doi: 10.1111/eci.12153
|
| 32 |
Yu.-I. Weng, Annayya R. Aroor, Shivendra D. Shukla. Ethanol inhibition of Angiotensin II-stimulated Tyr705 and Ser727 STAT3 phosphorylation in cultured rat hepatocytes: Relevance to activation of p42/44 mitogen-activated protein kinase. Alcohol 2008; 42(5): 397 doi: 10.1016/j.alcohol.2008.02.004
|
| 33 |
Yan Zhao, Kun Wu, Wei Xia, Yu-Juan Shan, Li-Jie Wu, Wei-Ping Yu. The effects of vitamin E succinate on the expression of <italic>c-jun</italic> gene and protein in human gastric cancer SGC-7901 cells. World Journal of Gastroenterology 2002; 8(5): 782-786 doi: 10.3748/wjg.v8.i5.782
|
| 34 |
Armin Thelen, Arne Scholz, Christoph Benckert, Zofia von Marschall, Maik Schröder, Bertram Wiedenmann, Peter Neuhaus, Stefan Rosewicz, Sven Jonas. VEGF‐D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma. International Journal of Cancer 2008; 122(11): 2471 doi: 10.1002/ijc.23439
|
| 35 |
Bing-Qing Chen, Ying-Ben Xue, Jia-Ren Liu, Yan-Mei Yang, Yu-Mei Zheng, Xuan-Lin Wang, Rui-Hai Liu. Inhibition of conjugated linoleic acid on mouse forestomach neoplasia induced by benzo (a) pyrene and chemopreventive mechanisms. World Journal of Gastroenterology 2003; 9(1): 44-49 doi: 10.3748/wjg.v9.i1.44
|
| 36 |
Cristian Scheau, Ioana Anca Badarau, Constantin Caruntu, Gratiela Livia Mihai, Andreea Cristiana Didilescu, Carolina Constantin, Monica Neagu. Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma. Molecules 2019; 24(13): 2350 doi: 10.3390/molecules24132350
|
| 37 |
Zhao-Shan Niu, Bo-Kian Li, Mei Wang. Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues. World Journal of Gastroenterology 2002; 8(5): 822-826 doi: 10.3748/wjg.v8.i5.822
|
| 38 |
Palak Parekh, K.V.K. Rao. Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine‐induced progressive liver carcinogenesis. Cell Biology International 2007; 31(1): 35 doi: 10.1016/j.cellbi.2006.09.005
|
| 39 |
Dirk Strumberg, Jeffrey W. Clark, Ahmad Awada, Malcolm J. Moore, Heike Richly, Alain Hendlisz, Hal W. Hirte, Joseph P. Eder, Heinz-Josef Lenz, Brian Schwartz. Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors. The Oncologist 2007; 12(4): 426 doi: 10.1634/theoncologist.12-4-426
|
| 40 |
Melanie B. Thomas, James P. O’Beirne, Junji Furuse, Anthony T. C. Chan, Ghassan Abou-Alfa, Philip Johnson. Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy. Annals of Surgical Oncology 2008; 15(4): 1008 doi: 10.1245/s10434-007-9705-0
|
| 41 |
Dong‐Xian Guan, Jie Shi, Yang Zhang, Jiang‐Sha Zhao, Ling‐Yun Long, Tian‐Wei Chen, Er‐Bin Zhang, Yuan‐Yuan Feng, Wen‐Dai Bao, Yue‐Zhen Deng, Lin Qiu, Xue‐Li Zhang, H. Phillip Koeffler, Shu‐qun Cheng, Jing‐Jing Li, Dong Xie. Sorafenib enriches epithelial cell adhesion molecule–positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2‐AKT cascade. Hepatology 2015; 62(6): 1791 doi: 10.1002/hep.28117
|
| 42 |
Miao-Wang Hao, Ying-Rui Liang, Yan-Fang Liu, Li Liu, Ming-Yao Wu, Huan-Xing Yang. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World Journal of Gastroenterology 2002; 8(2): 203-207 doi: 10.3748/wjg.v8.i2.203
|
| 43 |
Qiongqiong He, Ruixue Cheng, Zhuchu Chen, Xuxian Xiao, Zhiqiang Xiao, Cui Li, Bo Li, Pengfei Zhang, Hui Zheng, Deyun Feng. Cell Transformation and Proteome Alteration in QSG7701 Cells Transfected with Hepatitis C Virus Non-structural Protein 3. Acta Biochimica et Biophysica Sinica 2007; 39(10): 751 doi: 10.1111/j.1745-7270.2007.00344.x
|
| 44 |
|
| 45 |
Mark J. Hoenerhoff, Arun R. Pandiri, Stephanie A. Lahousse, Hu-Hua Hong, Tai-Vu Ton, Tiwanda Masinde, Scott S. Auerbach, Kevin Gerrish, Pierre R. Bushel, Keith R. Shockley, Shyamal D. Peddada, Robert C. Sills. Global Gene Profiling of Spontaneous Hepatocellular Carcinoma in B6C3F1 Mice. Toxicologic Pathology 2011; 39(4): 678 doi: 10.1177/0192623311407213
|
| 46 |
Yi-Long Xue, Shi-Feng Zhao, Yun-Luo, Xin-Jian Li, Zhong-Ping Duan, Xiao-Ping Chen, Wen-Ge Li, Xiao-Qiang Huang, Yan-Ling Li, Xin-Cui, Da-Guang Zhong, Zuo-Yun Zhang, Zhi-Qiang Huang. TECA hybrid artificial liver support system in treatment of acute liver failure. World Journal of Gastroenterology 2001; 7(6): 826-829 doi: 10.3748/wjg.v7.i6.826
|
| 47 |
Feng Han, Yu-Fei Zhang, Yun-Qing Li. Fos expression in tyrosine hydroxylase-containing neurons in rat brainstem after visceral noxious stimulation: an immunohistochemical study. World Journal of Gastroenterology 2003; 9(5): 1045-1050 doi: 10.3748/wjg.v9.i5.1045
|
| 48 |
Il Han Song. Molecular targeting for treatment of advanced hepatocellular carcinoma. The Korean Journal of Hepatology 2009; 15(3): 299 doi: 10.3350/kjhep.2009.15.3.299
|
| 49 |
Xiang-Tao Ma, Shan Wang, Ying-Jiang Ye, Ru-Yu Du, Zhi-Rong Cui, Ma Somsouk. Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World Journal of Gastroenterology 2004; 10(11): 1569-1573 doi: 10.3748/wjg.v10.i11.1569
|
| 50 |
Liang Sang, Xue-Mei Wang, Dong-Yang Xu, Li-Xuan Sang, Yang Han, Long-Yang Jiang. Morin enhances hepatic Nrf2 expression in a liver fibrosis rat model. World Journal of Gastroenterology 2017; 23(47): 8334-8344 doi: 10.3748/wjg.v23.i47.8334
|
| 51 |
Hicham Bouhlal, Hakim Ouled-Haddou, Véronique Debuysscher, Amrathlal Rabbind Singh, Christèle Ossart, Aline Reignier, Hakim Hocini, Gregory Fouquet, Mohammed Al Baghami, Mélanie Simoes Eugenio, Eric Nguyen-Khac, Jean-Marc Regimbeau, Ingrid Marcq. RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation. Oncotarget 2016; 7(9): 9832 doi: 10.18632/oncotarget.6954
|
| 52 |
Defeng Chang, Lanlan Li, Zhongqing Xu, Xiaohong Chen. Targeting FOS attenuates malignant phenotypes of breast cancer: Evidence from in silico and in vitro studies. Journal of Biochemical and Molecular Toxicology 2023; 37(7) doi: 10.1002/jbt.23358
|
| 53 |
Fang Li, Li Meng, Jianfeng Zhou, Hui Xing, Shixuan Wang, Gang Xu, Huaishi Zhu, Beibei Wang, Gang Chen, Yun-Ping Lu, Ding Ma. Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: A role of c-Jun NH2-terminal kinase 1. Biochemical and Biophysical Research Communications 2005; 335(4): 1070 doi: 10.1016/j.bbrc.2005.07.169
|
| 54 |
Ingrid Marcq, Rémy Nyga, Flora Cartier, Rabbind Singh Amrathlal, Christèle Ossart, Hakim Ouled-Haddou, Hussein Ghamlouch, Antoine Galmiche, Denis Chatelain, Luciane Lamotte, Véronique Debuysscher, Vincent Fuentes, Eric Nguyen-Khac, Jean-Marc Regimbeau, Jean-Pierre Marolleau, Sylvain Latour, Hicham Bouhlal, Michael Muders. Identification of SLAMF3 (CD229) as an Inhibitor of Hepatocellular Carcinoma Cell Proliferation and Tumour Progression. PLoS ONE 2013; 8(12): e82918 doi: 10.1371/journal.pone.0082918
|
| 55 |
Lidia Avalle, Gabriella Regis, Valeria Poli. Jak-Stat Signaling : From Basics to Disease. 2012; : 305 doi: 10.1007/978-3-7091-0891-8_17
|
| 56 |
Kun Wu, Yan Zhao, Gui-Chang Li, Wei-Ping Yu. c-Jun N-terminal kinase is required for vitamin E succinate-induced apoptosis in human gastric cancer cells. World Journal of Gastroenterology 2004; 10(8): 1110-1114 doi: 10.3748/wjg.v10.i8.1110
|
| 57 |
Dirk Strumberg, Heike Richly, Ralf A. Hilger, Norbert Schleucher, Sonke Korfee, Mitra Tewes, Markus Faghih, Erich Brendel, Dimitris Voliotis, Claus G. Haase, Brian Schwartz, Ahmad Awada, Rudolf Voigtmann, Max E. Scheulen, Siegfried Seeber. Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors. Journal of Clinical Oncology 2005; 23(5): 965 doi: 10.1200/JCO.2005.06.124
|
| 58 |
Shuiying Tang, Bihong Xu, Huajin Pang, Lijun Xiao, Quelin Mei, Xiaofeng He. Ozonated Water Inhibits Hepatocellular Carcinoma Invasion and Metastasis by Regulating the HMGB1/NF-κB/STAT3 Signaling Pathway. Journal of Hepatocellular Carcinoma 2023; : 203 doi: 10.2147/JHC.S394074
|
| 59 |
Meryem Güller, Kahina Toualbi-Abed, Agnès Legrand, Laurence Michel, Alain Mauviel, Dominique Bernuau, Fanny Daniel. c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1. World Journal of Gastroenterology 2008; 14(41): 6339-6346 doi: 10.3748/wjg.14.6339
|
| 60 |
Ai-Hong Meng, Yi-Ling Ling, Xiao-Peng Zhang, Xiao-Yun Zhao, Jun-Lan Zhang. CCK8 inhibits expression of TNF-α in the spleen of endotoxic shock rats and signal transduction mechanism of p38 MAPK. World Journal of Gastroenterology 2002; 8(1): 139-143 doi: 10.3748/wjg.v8.i1.139
|
| 61 |
Xavier Bisteau, Matias Caldez, Philipp Kaldis. The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations. Cancers 2014; 6(1): 79 doi: 10.3390/cancers6010079
|
| 62 |
Meng-Sen Li, Ping-Feng Li, Shi-Peng He, Guo-Guang Du, Gang Li. The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line. World Journal of Gastroenterology 2002; 8(3): 469-475 doi: 10.3748/wjg.v8.i3.469
|
| 63 |
Manali Dimri, Ande Satyanarayana. Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma. Cancers 2020; 12(2): 491 doi: 10.3390/cancers12020491
|
| 64 |
Fidel D. Huitzil‐Melendez, Ghassan K. Abou‐Alfa, Michael A. Morse. Malignant Liver Tumors. 2010; : 382 doi: 10.1002/9781444317053.ch32
|
| 65 |
Sunil Chada, Abner M. Mhashilkar, Rajagopal Ramesh, John B. Mumm, R. Bryan Sutton, Dora Bocangel, Mingzhong Zheng, Elizabeth A. Grimm, Suhendan Ekmekcioglu. Bystander activity of Ad-mda7: Human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism. Molecular Therapy 2004; 10(6): 1085 doi: 10.1016/j.ymthe.2004.08.020
|
| 66 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3007 doi: 10.1007/978-3-319-26956-6_167
|
| 67 |
Xuanming Zhang, Yongping Shi, Lizhen Wang, Xiaobin Li, Shanshan Zhang, Ximin Wang, Meng Jin, Chung-Der Hsiao, Houwen Lin, Liwen Han, Kechun Liu. Metabolomics for Biomarker Discovery in Fermented Black Garlic and Potential Bioprotective Responses against Cardiovascular Diseases. Journal of Agricultural and Food Chemistry 2019; 67(44): 12191 doi: 10.1021/acs.jafc.9b04073
|
| 68 |
Mariko Kusaba, Kazuhiko Nakao, Takashi Goto, Daisuke Nishimura, Hiroshi Kawashimo, Hidetaka Shibata, Yasuhide Motoyoshi, Naota Taura, Tatsuki Ichikawa, Keisuke Hamasaki, Katsumi Eguchi. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis. Journal of Hepatology 2007; 47(4): 546 doi: 10.1016/j.jhep.2007.04.017
|
| 69 |
Kathryn Z. Guyton, Thomas W. Kensler. Prevention of liver cancer. Current Oncology Reports 2002; 4(6): 464 doi: 10.1007/s11912-002-0057-4
|
| 70 |
R. Lord, A. Suddle, P. J. Ross. Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies. International Journal of Clinical Practice 2011; 65(2): 182 doi: 10.1111/j.1742-1241.2010.02545.x
|
| 71 |
S Whittaker, R Marais, A X Zhu. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010; 29(36): 4989 doi: 10.1038/onc.2010.236
|
| 72 |
Bao-Kang Wu, Qian-Hui Chen, Dan Pan, Bing Chang, Li-Xuan Sang. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer. International Immunopharmacology 2021; 96: 107790 doi: 10.1016/j.intimp.2021.107790
|
| 73 |
Raffaella Maria Gadaleta, Antonio Moschetta. Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver. Journal of Hepatology 2021; 75(6): 1440 doi: 10.1016/j.jhep.2021.07.029
|
| 74 |
Joseph D. Thomas, George A. Poultsides, Timothy M. Pawlick, Melanie B. Thomas. Gastrointestinal Oncology. 2011; : 225 doi: 10.1007/978-3-642-13306-0_9
|